← United States · Coverage record
US · SEC FORM 4
NewAmsterdam Pharma Co N.V.
NAMS · Nasdaq · CIK 0001936258 · Healthcare · Biotechnology
INSIDER SIGNAL
1 qualifying P purchase group
in the current 180-day scoring window
19 Form 4 transaction lines observed in the same window
9 sales · 9 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
—
Purchase breadth & concentration
Roles in the peak window: Chief Executive Officer. Concentration uses priced qualifying P lines only and does not change the saved score.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2026-09-14 · Davidson Michael H..
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 19,045,378
- Previous report
- 15,660,444
- Avg daily volume
- 2,028,041
- Days to cover
- 9.4
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-14 | Davidson Michael H. | Purchase (P) | Ordinary Shares | 10,000 | USD 22.65 | USD 226,500 | SEC filing ↗ |
| 2025-09-15 | Topper James N | Purchase (P) | Ordinary Shares | 660 | USD 23.70 | USD 15,642 | SEC filing ↗ |
| 2025-09-08 | Topper James N | Purchase (P) | Ordinary Shares | 1,260 | USD 24.99 | USD 31,487 | SEC filing ↗ |
| 2025-08-11 | Topper James N | Purchase (P) | Ordinary Shares | 471 | USD 23.98 | USD 11,295 | SEC filing ↗ |
| 2025-06-25 | Topper James N | Purchase (P) | Ordinary Shares | 1,260 | USD 18.26 | USD 23,008 | SEC filing ↗ |
| 2025-06-24 | Topper James N | Purchase (P) | Ordinary Shares | 2,520 | USD 18.43 | USD 46,444 | SEC filing ↗ |
| 2025-06-16 | Topper James N | Purchase (P) | Ordinary Shares | 8,584 | USD 19.50 | USD 167,388 | SEC filing ↗ |
| 2025-03-26 | Topper James N | Purchase (P) | Ordinary Shares | 1,135 | USD 22.49 | USD 25,526 | SEC filing ↗ |
| 2025-03-04 | Topper James N | Purchase (P) | Ordinary Shares | 4,005 | USD 21.02 | USD 84,185 | SEC filing ↗ |
| 2024-09-26 | Audet Juliette Berangere | Purchase (P) | Ordinary Shares | 1,104 | USD 15.70 | USD 17,333 | SEC filing ↗ |
| 2024-08-20 | Davidson Michael H. | Purchase (P) | Ordinary Shares | 5,000 | USD 16.27 | USD 81,350 | SEC filing ↗ |
| 2024-06-20 | Davidson Michael H. | Purchase (P) | Ordinary Shares | 5,000 | USD 17.26 | USD 86,300 | SEC filing ↗ |
| 2024-03-26 | Topper James N | Purchase (P) | Ordinary Shares | 8,429 | USD 21.50 | USD 181,224 | SEC filing ↗ |
| 2024-02-13 | LANGE LOUIS G | Purchase (P) | Ordinary Shares | 5,000 | USD 19.00 | USD 95,000 | SEC filing ↗ |
Form 4 evidence
81 transaction lines in the latest 365-day window; 200 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | Kastelein Johannes Jacob Pieter | Sale (S) | Ordinary Shares | 50,246 | USD 25.03 | USD 1,257,657 | SEC filing ↗ |
| 2026-09-30 | Kastelein Johannes Jacob Pieter | Option exercise / conversion (M) | Ordinary Shares | 50,246 | USD — | USD — | SEC filing ↗ |
| 2026-09-14 | Davidson Michael H. | Purchase (P) | Ordinary Shares | 10,000 | USD 22.65 | USD 226,500 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | Kastelein Johannes Jacob Pieter | Sale (S) | Ordinary Shares | 50,246 | USD 25.03 | USD 1,257,657 | SEC filing ↗ |
| 2026-09-30 | Kastelein Johannes Jacob Pieter | Option exercise / conversion (M) | Ordinary Shares | 50,246 | USD — | USD — | SEC filing ↗ |
| 2026-09-14 | Davidson Michael H. | Purchase (P) | Ordinary Shares | 10,000 | USD 22.65 | USD 226,500 | SEC filing ↗ |
| 2026-09-04 | Smither John W | Sale (S) | Ordinary Shares | 1,600 | USD 25.32 | USD 40,512 | SEC filing ↗ |
| 2026-09-01 | Gunning Robert William | Award / grant (A) | Ordinary Shares | 3,200 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-24 | Kastelein Johannes Jacob Pieter | Sale (S) | Ordinary Shares | 125,000 | USD 26.91 | USD 3,363,750 | SEC filing ↗ |
| 2026-08-24 | Kastelein Johannes Jacob Pieter | Option exercise / conversion (M) | Ordinary Shares | 125,000 | USD — | USD — | SEC filing ↗ |
| 2026-07-20 | Kooij Louise Frederika | Sale (S) | Ordinary Shares | 105,000 | USD 30.34 | USD 3,185,656 | SEC filing ↗ |
| 2026-07-20 | Kooij Louise Frederika | Option exercise / conversion (M) | Ordinary Shares | 105,000 | USD 11.34 | USD 1,191,100 | SEC filing ↗ |
| 2026-06-22 | Kooij Louise Frederika | Sale (S) | Ordinary Shares | 40,000 | USD 30.20 | USD 1,208,159 | SEC filing ↗ |
| 2026-06-22 | Kooij Louise Frederika | Option exercise / conversion (M) | Ordinary Shares | 40,000 | USD 11.28 | USD 451,000 | SEC filing ↗ |
| 2026-05-26 | Kooij Louise Frederika | Sale (S) | Ordinary Shares | 65,000 | USD 35.69 | USD 2,319,850 | SEC filing ↗ |
| 2026-05-26 | Kooij Louise Frederika | Option exercise / conversion (M) | Ordinary Shares | 65,000 | USD 10.07 | USD 654,500 | SEC filing ↗ |
| 2026-03-11 | LANGE LOUIS G | Sale (S) | Ordinary Shares | 44,619 | USD 30.42 | USD 1,357,230 | SEC filing ↗ |
| 2026-03-09 | LANGE LOUIS G | X (X) | Ordinary Shares | 44,619 | USD 11.50 | USD 513,118 | SEC filing ↗ |
| 2026-03-09 | Kastelein Johannes Jacob Pieter | Sale (S) | Ordinary Shares | 101,409 | USD 30.29 | USD 3,071,679 | SEC filing ↗ |
| 2026-03-09 | Kastelein Johannes Jacob Pieter | Option exercise / conversion (M) | Ordinary Shares | 101,409 | USD — | USD — | SEC filing ↗ |
| 2026-03-06 | LANGE LOUIS G | Sale (S) | Ordinary Shares | 28,186 | USD 29.41 | USD 828,950 | SEC filing ↗ |
| 2026-03-06 | Kastelein Johannes Jacob Pieter | Sale (S) | Ordinary Shares | 94,124 | USD 30.32 | USD 2,853,840 | SEC filing ↗ |
| 2026-03-06 | Kastelein Johannes Jacob Pieter | Option exercise / conversion (M) | Ordinary Shares | 94,124 | USD — | USD — | SEC filing ↗ |
| 2026-03-05 | Kastelein Johannes Jacob Pieter | Sale (S) | Ordinary Shares | 104,467 | USD 30.30 | USD 3,165,350 | SEC filing ↗ |
| 2026-03-05 | Kastelein Johannes Jacob Pieter | Option exercise / conversion (M) | Ordinary Shares | 104,467 | USD — | USD — | SEC filing ↗ |
| 2026-03-02 | Davidson Michael H. | Sale (S) | Ordinary Shares | 443,707 | USD 33.25 | USD 14,753,258 | SEC filing ↗ |
| 2026-03-02 | Davidson Michael H. | Option exercise / conversion (M) | Ordinary Shares | 443,707 | USD — | USD — | SEC filing ↗ |
| 2026-02-26 | Davidson Michael H. | Sale (S) | Ordinary Shares | 183,332 | USD 33.71 | USD 6,179,974 | SEC filing ↗ |
| 2026-02-26 | Davidson Michael H. | Option exercise / conversion (M) | Ordinary Shares | 183,332 | USD — | USD — | SEC filing ↗ |
| 2026-02-25 | Davidson Michael H. | Sale (S) | Ordinary Shares | 58,253 | USD 35.30 | USD 2,056,174 | SEC filing ↗ |
| 2026-02-25 | Davidson Michael H. | Option exercise / conversion (M) | Ordinary Shares | 58,253 | USD — | USD — | SEC filing ↗ |
| 2026-02-24 | Davidson Michael H. | Sale (S) | Ordinary Shares | 64,708 | USD 36.15 | USD 2,338,943 | SEC filing ↗ |
| 2026-02-24 | Davidson Michael H. | Option exercise / conversion (M) | Ordinary Shares | 64,708 | USD — | USD — | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | NAMS |
| CIK | 0001936258 |
| Sector | Healthcare |
| Industry | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 200 transaction lines from 2024-02-13 to 2026-09-30 14 P purchase lines · 102 S sale lines · 84 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.